Hepatic Metastases Recruiting Phase 1 Trials for Tremelimumab (DB11771)

Also known as: Metastases to liver / Liver Metastases / Metastatic neoplasm of liver / Cancer of liver, secondary / Metastasis to liver / Malignant neoplasm of liver, specified as secondary

IndicationStatusPhase
DBCOND0032606 (Hepatic Metastases)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02754856Tremelimumab (Anti-CTLA-4) Plus Durvalumab (MEDI4736) (Anti-PD-L1) in the Treatment of Resectable Colorectal Cancer Liver MetastasesTreatment